Trial Design Finalized in Consultation and Alignment with U.S. Food and Drug Administration Study Designed to Establish a New Standard for Adult ...
Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the province of Saskatchewan has added CAPVAXIVE®, a 21-valent pneumococcal conjugate vaccine, to its ...
Learn why child mortality is rising for the first time in our lives - and how smarter investments, innovation, and science ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback